DIABETES - A Major Threat to Global Health

Major cause of adult-onset blindness, cardiovascular disease, and renal failure.

Current diabetes treatments rely heavily on cold chain logistics, which are unavailable in many developing countries and rural areas.

Regions like India and Africa, among others, suffer from the lack of a cold chain infrastructure and uninterrupted power supply, making storage, transport, and accessibility of insulin a significant challenge.

1 DEATH
every
10s
1 AMPUTATION
every
30s
People
sufferring from diabetes
800M+
Asia and Africa suffer >60% of diabetic deaths

Critical Gap in Diabetes Care

Vital medicines like Insulin degrade and lose their efficacy without proper refrigeration, and the lack of access to high-quality insulin leads to devastating consequences like amputations and kidney failures faced by patients in these regions.

InStrongTM

The extra stable Insulin

Breaking Boundaries to Redefine Diabetes Care

InstrongTM, our flagship product, utilizes our proprietary ProteostrongTM technology to create thermostable insulin that can be stored and transported at room temperature, even in hotter climates.

The InStrongTM Advantage:

5X higher stability
Stability sustained over time at 50°C
Accessible to everyone

Shaping the Future of Diabetes Care

0

days wait time

Lamark ensures the availability of insulin in rural regions without cold chain logistics and storage. This prevents missed dosages in rural areas due to unavailability, thus leading to increased life expectancy and quality of life.

0

missed dosages due to insulin unavailability

InStrongTM can meet WHO targets of 80% accessibility even in the remote areas.

Our Pipeline

Redefining what’s possible in diabetes care.

We’re combining innovation with measurable outcomes to deliver lasting impact.

Interested in partnering with us? We’d love to connect. Reach out today!
Write to Us